| Report ID | 282676 |
| Drug Identification Number | 02297558 |
| Brand name | MEZAVANT |
| Common or Proper name | Mesalamine delayed- and extended-release tablets |
| Company Name | TAKEDA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | MESALAZINE |
| Strength(s) | 1.2G |
| Dosage form(s) | TABLET (DELAYED AND EXTENDED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 120 tablets / bottle |
| ATC code | A07EC |
| ATC description | INTESTINALANTIINFLAMMATORY AGENTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2026-04-10 |
| Actual start date | 2026-04-10 |
| Estimated end date | 2026-04-21 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-04-10 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-04-10 | French | Compare |
| v3 | 2026-04-10 | English | Compare |
| v2 | 2026-04-10 | French | Compare |
| v1 | 2026-04-10 | English | Compare |
Showing 1 to 4 of 4